EFFECT OF IMMUNOSUPPRESSION ON CHRONIC LCM VIRUS INFECTION OF MICE by Hoffsten, Phillip E. & Dixon, Frank J.
EFFECT  OF  IMMUNOSUPPRESSION  ON  CHRONIC  LCM  VIRUS 
INFECTION  OF  MICE* 
PHILLIP E.  HOFFSTEN$ AND FRANK J.  DIXON 
(From the Department of Experimental  Pathology, Scripps Clinic and 
Research Foundation, La Jolla,  California 92037) 
(Received  for  publication  14  June  1973) 
Mice chronically infected with lymphocytic choriomeningitis (LCM)  1 virus were 
once thought to be immunologically tolerant to this virus (1). In 1963, Volkert trans- 
ferred syngeneic immune spleen cells to mice that were chronic LCM carriers, thus 
ablating what was  then  thought  to be a  tolerant ,;tate. Adoptive immunization of 
these mice resulted in measurable titers of complement-fixing antibody to LCM viral 
antigens when previously there had been none  (2).  Associated with rising antibody 
titers were decreasing plasma virus titers, thus indicating that the animal's state of 
immunity played a  role in determining the virus titer in its plasma. 
In 1967, Oldstone and Dixon (3) demonstrated that mice chronically infected with 
LCM virus were not immunologically  tolerant but instead mounted antibody responses 
to viral antigens after which circulating immune complexes were formed and deposited 
in  their glomeruli. Antibody responses to LCM  antigens in unmanipulated chronic 
carrier mice have not yet been quantitated, but it has been shown that sufficient anti- 
LCM antibody is produced to complex with at least 99 % of the circulating LCM virus 
(4). Possibly, then, immune responses of chronic LCM carriers may play some role in 
attenuating the amount of virus carried by these mice. 
The  studies in this report were directed toward evaluating what effect sup- 
pression of the LCM immune response would have on the amounts of this viral 
antigen  in  tissues  and  infectious  virus  in  plasma of  chronic  carrier mice.  In 
addition,  histological,  hematological,  and  immunopathologic  data  were  col- 
lected on  both  immunosuppressed  and  unmanipulated  mice. 
* This is publication number 721 from the Department of Experimental Pathology, Scripps 
Clinic  and  Research  Foundation, La Jolla, Calif.  This research  was  supported by Atomic 
Energy Commission Contract AT(04-3)410 and U.S. Public Health Service grant AI-07007. 
:~ Recipient of  U.S.  Public Health  Service Training grant 5T1GM683.  Present address: 
Renal  Division,  Department  of  Medicine,  Washington  University  School  of  Medicine, 
St. Louis, Mo. 63110. 
1Abbreviatlons used in this paper: FITC, fluorescein isothiocyanate; I.C., intracerebrally; 
KLH,  keyhole  limpet hemocyanin; LDV,  lactic dehydrogenase  virus; LCM,  lymphocytic 
choriomeningitis;  PAS,  p-aminosalicylate; PBS, phosphate-buffered  saline;  SAS, saturated 
ammonium  sulfate. 
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Materials and Methods 
Mice.--SWR/J inbred breeders were obtained from Jackson Memorial Laboratories,  Bar 
Harbor,  Me.  Pregnant  C3H  mice  were  obtained  from  L. C.  Strong Research Foundation, 
San Diego, Calif. 4-6-wk old Swiss-Webster mice for LCM virus titrations were obtained from 
Simonsen Laboratory,  Gilroy, Calif. 
LCM Virus.--LCM  virus used was strain CA-1371 originally obtained from Dr. Wallace 
Rowe  of  the National  Institute  of Allergy and Infectious  Diseases, Bethesda,  Md.  It  was 
passed on L  cell monolayers in our laboratory, and a  106 LD~0 dose was inoculated intracere- 
brally  (I.C.) into each newborn mouse. The method of virus titration used in this laboratory 
has been previously described  (5). 
lmmunosuppressive Agents.--Cyclophosphamide  was  obtained  from  Mead  Johnson and 
Co., Evansville, Ind., and a  solution prepared  by adding water to the ampoule immediately 
before  use.  The  drug was injected  intraperitoneally  (i.p.)  at  a  concentration  of  10  mg/ml 
diluent, doses being administered based  on each animal's weight. X-irradiation was adminis~ 
tered via a  Gammacel Irradiator  (Atomic Energy of Canada, Ltd. Ottawa, Canada) using a 
Cesium 137 source emitting 125 R/min. Varying times of exposure were used to obtain different 
doses of irradiation. 
lmmunofluorescent-Histopathologic Techniques.--Methods  used were  similar  to  those pre- 
viously described from this laboratory  (4)  except as noted below. Mice to be autopsied were 
etherized and exsanguinated by cutting the brachial vessels. Cmnplete blood counts were done, 
and the serum was saved for virus titration and immunoglobulin determinations. Tissues were 
fixed in Bouin's solution for standard  hematoxylin-eosin and p-aminosalicylate (PAS)  stains. 
Additional  tissue was frozen for  in liquid  nitrogen immunofluorescent examination.  Rabbit 
antisera for mouse immunoglobulin, mouse third component of complement, rat fibrlnogen, 
and mouse albumin were prepared as previously described (4). In all cases the rabbit immuno- 
globulin was isolated, conjugated to fluorescein i~othiocyanate (FITC), and again fractionated 
on DEAE;  the 0.05 M  PO4 or 0.1  M  PO4 fractions were used unabsorbed  to  stain unfixed 
mouse tissues. Anti-LCM antiserum was prepared from the blood of the mothers of the LCM 
infected neonates. The mothers were exsanguinated 28 days after their litters were born, and a 
50%  saturated  ammonium sulfate  (SAS)  cut of  the  serum so obtained  was conjugated  to 
FITC. The conjugate was then fractionated on DEAE and the 0A M  PO~ fraction used for 
staining tissues after absorption with 6-mo to 1-yr old NZB  X  NZW washed kidney homoge- 
nate. This step was necessary to remove antibodies found to be present which stained mouse 
glomeruli having immune complexes resulting from etiologies other than chronic LCM virus 
infection. The absorbed anti-LCM conjugate stained only tissue from animals infected with 
LCM virus. 
Immunoglobulin Determinatlons.--Radial  immunodiffusiou techniques were  used  as  pre- 
viously described by Mancini et al.  (6).  Murine immunoglobulin purified by Pevikon block 
electrophoresis was used as a  standard and also as immunogen to raise the rabbit antiserum 
used. 
Precipitation of LCM Virus-Immunoglobulin Complexes.--The procedure used was a modifi- 
cation of that previously reported by Notkins et al.  (7) in working with lactic dehydrogenase 
virus (LDV)  infection of mice. Infectious serum was used fresh or after extended storage at 
--70°C. To 50X of infectious mouse serum was added 10X of 125I trace-labeled purified mouse 
immunoglobulin. Then 200X of 56°C heat inactivated rabbit antiserum to the 50% SAS cut of 
normal mouse serum was added. The mixture was incubated for 15 min at 37°C and 30 rain at 
4°C. It was next centrifuged for 30 rain at 3,000 rpm in an International PR-6 centrifuge and a 
200~ aliquot of supernatant removed. The aliquot of supernatant was added to an additional 
200X  of the precipitating  rabbit  antiserum and a  second incubation of  15  rain  at 4°C, etc. 
carried out. The supernatant from the second centrifugation was then analyzed for remaining 
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tested for infectivity by serial 10-fold dilutions injected I.C. into Swiss-Webster mice as de- 
scribed above. Some mouse sera tested had immunoglobulin concentrations that exceeded the 
precipitating capacity of the rabbit antiserum as used above. These were diluted 1:2 in phos- 
phate-buffered saline (PBS) and then carried through the procedures as before. Controls in- 
cluded: (a) Attempts to precipitate LCM virus grown on L cells which had no immunoglobulin 
present on its surface. No measurable precipitation of infectivity occurred when this virus was 
first mixed with heat inactivated normal mouse  serum and carried through the above  procedure. 
(b) Use of rabbit antiserum to mouse albumin as the precipitating antiserum. No loss of in- 
fectivity occurred. 
RESULTS 
Prevention of Immune Response to LCM Virus.--12 normal 6-wk old SWR/J 
male mice were given 4 weekly doses of 300 R. Several hours after the fourth 
dose  of  irradiation,  106  LDs0  of LCM  virus  was  administered  I.C.  Weekly 
doses of x-irradiation of 300 R  were continued for 6-8 wk more at which time 
the mice were sacrificed. 
The virus titer in plasma from these mice at the time of sacrifice  was 102.7±0.3 
LDs0/0.03  rnl  and  circulating  immunoglobulin-virus  complexes  were  not 
demonstrated in  any of four mice examined.  Immunoglobulin levels were 0.4 
mg/ml with a  range of 0.2  mg/ml to 0.6 mg/ml  (normal 2.3  -4-  0.4 mg/ml). 
There was no histologic evidence of acute inflammatory disease characteristic 
of acute LCM infection. As expected of mice that had been infected for only 
6-8 wk, no histopathologic evidence of chronic glomerular disease was noted. 
Immunofluorescent examination of each mouse's kidney, liver, and brain showed 
a  distribution  of  LCM  antigen  similar  to  that  in  neonatally  infected  mice 
without associated Ig and C and no immune deposits in glomeruli. 
In a second experiment 20 SWR/J male mice were given a LD~0 x-irradiation 
dose  of  700  R,  a  dose  shown  to  suppress  the  primary  immune  response  to 
keyhole limpet  hemocyanin (KLH)  for at  least  1 too,  and  infected with  106 
LD~0 of LCM virus I.C. 36 h later. No further irradiation was given. 10 of the 
mice died within 2 wk. Plasma from the remaining 10 mice had virus titers of 
103.5±o.2 LDs0/0.03 ml 2 mo after infection. This value was the same4 mo after 
infection at which time the mice were sacrificed.  At this time immunoglobulin 
was complexed to virus in their plasma indicating that the  mice had recovered 
from the  radiation  and were  synthesizing anti-LCM antibody. After 99%  of 
the plasma immunoglobulin had been precipitated,  virus titers in  the plasma 
decreased two logs.  The average concentration of serum immunoglobulin was 
within normal limits,  2.1  mg/ml  with  a  range  of  1.9  mg/ml  to  2.4  mg/ml. 
Heavy PAS  positive glomerular deposits  were  seen  on histopathological  ex- 
amination,  and immunofluorescence showed marked glomerular deposition  of 
murine immunoglobulin and complement. 
Suppression of an Established Immune Response.--This portion of the study 
utilized  SWR/J  and  C3H  mice  infected  neonatally  with  106 LDs0  of LCM 
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injections began when  the  mice  were 2-too old and continued weekly for the 
duration of the experiments. 
In Table I are shown the virus titers of C3H mice which underwent immuno- 
suppressive  procedures  for  1  too.  The  dose  of  x-irradiation  was  150  R  per 
week,  the largest amount of radiation tolerated by uninfected mice. The dose 
of cyclophosphamide was 50 mg/kg body weight per week,  a  dose  shown to 
suppress  a  primary  response  to  KLH in  preliminary  investigations.  As  can 
be seen,  the virus titers increased by about 100.5 for control-, irradiated-,  and 
cyclophosphamide-treated animals.  Thus the experimental manipulations had 
no apparent effect for the short time the mice were studied. 
During  the  course  of  the  experiments,  the  C3H  mice neonatally infected 
with LCM virus became ill, and they died after only 4-6 wk of treatment. We 
found that these mice had become pancytopenic and hypogammaglobulinemic 
TABLE  I 
Virus Titers of LCM Carrier  C3H Mouse Plasma; Loglo  SW Mouse LDso/O.03 ml I. C. 
Age of mouse  Controls  150 R/wk  Cytoxan 
mo  50 mg/kg per wk i.p. 
2  3.4  4-  0.4  3.3  +  0.4  3.3  4-  0.5 
8 mice  11 mice  12 mice 
3  3.7  4-  0.4  3.8  i  0.4  4.0  4-  0.3 
8 mice  6 mice  8 mice 
as a result of bone marrow aplasia in response to only 150 R per week of irradi- 
ation. Autopsies showed aplasia of all lymphoid organs but no apparent altera- 
tion  in  the  glomerulonephritis  which  was  very mild  at  the  age  of the  mice 
studied.  Because  of  the  extreme  radiosensitivity  of  the  LCM-infected  C3H 
mice in which only six doses of x-irradiation were invariably fatal, these studies 
were discontinued. 
The  SWR/J  mouse  proved  to  tolerate  immunosuppression  better,  thus 
allowing  extended  observations.  In  Table  II  are  shown  the  virus  titers  of 
immunosuppressed SWR/J mice neonatally infected with LCM virus and  the 
doses of immunosuppressant are indicated. No significant change in virus titer 
was noted for the various doses of suppressants  used.  Immunoglobulin com- 
plexed  to virus was present  in  the plasma of four out of four mice tested  in 
the  300  R/wk  irradiated  group  after  5  wk  of  treatment  indicating an anti- 
LCM response persisted.  In the group given the larger dose of cyclophospha- 
mide,  five out of eight mice tested  after 4  mo of immunosuppression had no 
detectable immunoglobulin complexed to virus. 
The degree of immunoglobulin depression resulting from the larger doses of 
immunosuppressant  in  SWR/J mice is  shown in  Fig.  1.  As can be  seen,  the 
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TABLE  II 
Virus Titers of LCM Carrier  SWR/J  Mouse Plasma; Loglo  SW Mouse LDso/O.03 ml I. C. 
Age of  Untreated controls  Cytoxan  Cytoxan  Irradiation  Irradiation  mouse 
mo  50 mg/kg per wk  70 mg/kg per wk 
2  4.0  4-  0.3  4.0  4-  0.3  4.1  4-  0.4 
3  4.0  4-  0.3  3.5  4-  0.1 
4  3.9  4-  0.5  4.0  4-  0.2  3.7  4-  0.4 
5  4.1  4-  0.4 
6  4.1  4-  0.2  3.9  4-  0.2  4.3  4-  0.6 
7  3.7  4-  0.2 
8  3.5  ±  0.2  3.9  4-  0.3  3.7  4-  0.4 
10  3.7  4-  0.3  3.7  4-  0.2 
150 R/wk  300 R/wk 
4.0  4-  0.3  4.0  4-  0.3 
4.4  4-  0.6 
4.3  4-  0.3 
5- 
4- 
3. 
2- 
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1" 
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FIG.  1.  Effect  of  immunosuppression on  serum  immunoglobulin levels  of  SWR/J  mice 
chronically infected with LCM virus. 
when  cyclophosphamide was  used.  The mice given 300  R/wk  of irradiation 
also  had  decreases  in  serum  immunoglobulin  levels  but  the  procedure  was 
soon lethal, ending further observations. 
The  glomerulonephritis  of  untreated  SWR/J  mice  chronically  infected 
with LCM virus is illustrated in the series of pictures A-E (Fig. 2) that shows 
progressive increases  in  the  amount  of PAS  positive glomerular deposits  at 
2, 4, 6, 8, and 10 mo. For comparison, the glomerulus in F  is from an 8-mo old 
mouse treated with cyclophosphamide for 6 mo. 24 of 26 mice treated with 70 
mg cyclophosphamide  per  kilogram body weight  had no glomerular disease. 
The two mice that developed glomerular disease while being given cyclophos- 892  IMMUNOSUPPRESSION  ON  CHRONIC  LCI~  VIRUS  INFECTION 
Fro. 2.  Series of glomeruli from SWR/J mice infected with LCM virus for (A) 2 m~, (B) 
4 mo, (C) 6 too, (D) 8 mo, and (E)  10 mo. Progressive deposition of glomerular PAS positive 
material is shown. In (F) is glomerulus from 8-too old mouse treated with cyclophosphamide 
for 6 mo showing absence cf PAS positive material. (X  400, PAS) 
phamide were  lymphoid depressed as measured  by depressed serum immuno- 
globulin levels and decreased peripheral white blood cell counts.  One of these 
two mice was  tested for immunoglobulin complexed to LCM  virus and com- 
plexes were present indicating a  persistent anti-LCM response. 
Fig.  3  shows  representative  immunofluorescent  studies  of  glomeruli  from 
cyclophosphamide  treated  and  control  8-mo  old  SWR/J  mice  chronically PHILLIP  E.  HOFFSTEN  AND  :FRANK  ~.  DIXON  893 
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infected with LCM virus. As described in the legend for Fig. 3, immunoglobulin 
and  czmplement  deposits  found  in  control  mice  were  prevented  by  cyclo- 
ph3sphamide  administration  to  the  experimental  group.  24 of 26 cyclophos- 
phamide-treated mice had no or very little immune complex deposition in their 
glomeruli. 
Frozen sections of liver, kidney,  and  brain  stained  with  a  fluorescein con- 
jugated  anti-LCM  antiserum  were  examined  to  assess  the  amount of LCM 
antigen; marked variation in the amount of antigen occurred from one mouse 
to the next in all groups. However, on the average, control and immunosup- 
pressed  groups had  comparable  amounts  and  distribution  of  tissue  antigen. 
Shown in  Fig.  4  is  the  distribution  of LCM  antigen  in  tubules  of a  kidney 
section. The percent of tubules on a given section which were p~sitive for LCM 
antigen varied from 2 %  to 30 %. No group of mice had  a  percent  of positive 
tubules statistically different from other groups. Thus, as with the virus titers 
in  plasma,  immunosuppression  did  not  increase  quantities  of  immunohisto- 
chemically detectable LCM virus antigen in tissues.  There was no difference 
between  the  small  amount of LCM viral  antigen  deposited  in  the  glomeruli 
of control and immunosnppressed mice.  Microscopic sections of liver,  spleen, 
brain,  kidney, lung, heart,  bone marrow,  thymus,  and  a  portion of intestine 
were  scanned for the presence of tumors. A  total  of  140 uninfected  and  225 
LCM-infected mice  were  examined.  One  case  of  lymphocytic leukemia  was 
FIG. 4. LCM antigen in the tubules and a glomerulus (arrow) of kidney from a 6-mo old 
SWR/J mouse chronically infected with LCM virus. Antigen positive tubules appeared in 
groups such as shown here; most tubules were antigen negative in both control and immuno- 
suppressed mice. Little antigen was seen in glomeruli and immunosuppressive manipulations 
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found in a  10-too old control SWR/J mouse. Two pulmonary adenomas were 
found in uninfected  control  SWR/J mice; none were found in LCM-infected 
mice. Neoplasms were not seen in any of the cyclophosphamide treated or x-ir- 
radiated  mice of the  SWR/J  strain.  Neoplasms were not seen in  any of the 
control or immunosuppressed C3H mice. 
DISCUSSION 
Our studies were directed  toward assessing the role played by the immune 
response in determining the  titer of virus in plasma and  the amount of viral 
antigen  in  tissues of mice acutely and chronically infected  with LCM  virus. 
This problem was approached by using two methods: the first was to prevent 
primary immune responses in adult mice by irradiation with 4 weekly doses of 
300  R  preceding  infection  with  LCM  virus.  As  noted,  the  amount  of virus 
that irradiated mice continued  to carry was no different from that carried by 
neonatally infected nonsuppressed mice of the same age. No acute disease and 
no glomerular immune deposits were seen, and immunoglobulin complexed to 
circulating virus was not demonstrated, indicating  that the humoral immune 
response to the virus had been prevented. An alternative methoJ of inducing 
the LCM carrier state in adult mice was infecting mice 36 h  after a single dose 
of 700  R  x-irradiation.  This treatment did not prevent the late development 
of  glomerulonephritis,  and  immunoglobulin  complexed circulating  virus  was 
present 2 mo after the carrier state was induced indicating a  recovery of anti- 
body formation. 
The second method of assessing the role of the immune response in chronic 
LCM  infection  was  to  immunosuppress  neonatally-infected  mice  after  they 
reached  2  mo  of  age.  These  mice  already  had  circulating  immunoglobulin 
complexed virus and immune deposits in their glomeruli. Thus,  the task was 
to  ablate  an  established  immune  response,  a  situation  more  applicable  to 
therapy of disease in progress. Here x-irradiation in maximally tolerated doses 
was  ineffective in  suppressing  antiviral  antibody  formation  as  indicated  by 
the persistence of immunoglobulin-virus complexes in the circulation, although 
glomerular  accumulation  of immune complexes was prevented.  By contrast, 
weekly doses of cyclophosphamide given over a  prolonged period were effec- 
tive in clearing the circulation of immunoglobulin complexed to virus in some 
cases.  Prolonged  cyclophosphamide administration  was  also  effective in  pre- 
venting glomerular immune complex deposition in over 90 % of the mice treated. 
However, neither  x-irradiation  nor cyclophosphamide altered  the  amount  of 
virus carried by these mice. 
It  has  not  been  possible  to  establish  the  potential  roles  of  humoral  and 
cellular  immune responses  on virus  levels in  chronic  LCM  infection.  In  our 
experiments it is clear that the levels of antibody achieved in the infected ani- 
mals alone is not a potent regulator of LCM levels since their suppression caused 
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was achieved by the x-ray and cyclophosphamide doses employed also did not 
affect LCM  levels.  If  one  assesses  cellular  immune  function  by  skin  graft 
survival,  cyclophosphamide is not an impressive cellular immunosuppressant 
(8). The effect of x-irradiation on cellular immune mechanisms depends on a 
number of variables  as discussed  by Taliaferro et al.  (9).  The work of Uhr 
and  Scharff (10)  indicates  that  established  cellular immunity is not ablated 
by subsequent sublethal irradiation.  It is thus probable that some degree of 
cellular immunity persisted  in  our irradiated mice  chronically infected with 
LCM. 
Our data agree with and extend the results of others.  Sharon and Pollard 
(11)  administered cyclophosphamide to LCM-infected Haas strain gnotobiotic 
mice. They stated that there was no change in virus titers over a 5-too period 
although neither quantitation  of virus titers nor demonstration of the  effec- 
tiveness of immunosuppression was presented. Our data include quantitative 
determinations of total  serum  Ig  suppression  in  cyclophosphamide and  also 
x-ray treated mice  (Fig.  1).  In  addition,  we were  able  to  show  that  LCM- 
specific antibody complexed to the circulating virus could be suppressed with- 
out altering the plasma virus titer. In 1956, Rowe (12)  first noted that virus 
titers in adult mice given single doses of x-irradiation before LCM infection 
remained unaltered from control nonirradiated acutely infected mice. Hotchin 
and Weigand  (13)  made  similar observations. While a  single  dose of irradia- 
tion at the time of LCM infection of an adult mouse may be life saving, our 
data show  that  a  subsequent  anti-LCM  humoral  imnmne  response does de- 
velop just as in the neonatally-infected mice. We found that continued weekly 
irradiation could prevent the humoral response and yet not alter the plasma 
virus titers. Recently, Brojorgansen et al. administered a single dose of x-irradi- 
ation to C3H mice chronically infected with LCM virus. Virus titers in plasma 
were unchanged in spite of excessive mortality resulting from stem cell lesions 
after doses of x-irradiation  that  were sublethal  for uninfected mice  (14).  In 
confirmation, we found that  C3H mice chronically infected with LCM  virus 
developed bone marrow aplasia  and died after irradiation doses tolerated by 
SWR/J mice. Sharon has reported similar radiation sensitivity in Haas strain 
gnotobiotic mice chronically infected with LCM virus (15). 
Effects of cyclophosphamide on various chronic viral infections have been 
investigated with different results. In chronic LDV infection of mice, Dubey 
et al.  (16) observed increased virus titers in plasma after 2 mo of weekly cyclo- 
phosphamide  administration,  although  the  mice  underwent  no  obvious  ill 
effects. Cheema et al.  (17) noted a log increase in virus titer of mink  infected 
with Aleutian disease and treated with cyclophosphamide; glomerular immune 
complex deposition which occurs in unmanipulated mink infected with Aleutian 
disease virus was prevented. Thus,  in  these  two  chronic viral infections the 
quantities of virus carried by the hosts  apparently were increased by immuno- 
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There is speculation in  the literature  that some  chronic glomerulonephritis 
in  humans  are  caused  by chronic  viral  infections  (18,  19).  Although  cyclo- 
phosphamide has not been proven generally beneficial to patients with chronic 
immune complex glomerulonephritis  (20-27),  experimental results of this and 
other reports (11,  17, 28) may encourage further trials. 
Prolonged immunosuppressive therapy of the disease occurring in  (NZB  X 
NZW)F1 hybrids may cause increased  incidence  of neoplasia in  the  females. 
Walker and Bole reported malignancies of various types in  6  out of 10 mice 
given daily injections of 8 mg of cyclophosphamide per kilogram body weight 
for 36-64 wk (29). Russell and Hicks reported a 29 % incidence of neoplasms of 
various  types in  76  mice given long term cyclophosphamide treatment  (28). 
This contrasts sharply with the total absence of neoplasia in our immunosup- 
pressed  SWR/J  mice  chronically  infected  with  LCM  virus.  The  absence  of 
tumors in our SWR/J mice treated for 6 m ~ may be explained by differences 
inherent  in  the  mouse  strains  or  by the  shorter  period  of treatment  of our 
mice. 
SUMMARY 
C3H  mice chronically infected with LCM  virus were found to be lethally 
affected by small doses of imrnunosuppression  which caused bone marrow 
aplasia but had no effect on the amount of virus carried by the mouse. Humoral 
immune  response of SWR/J  mice to  acute  LCM  infection  was  found  to  be 
totally  suppressed by repeated  single  doses of 300  R/wk  with  no  alteration 
in  the  level of virus carried by the mouse.  In contrast,  the  established  anti- 
LCM humoral immune response encountered in mice chronically infected with 
LCM virus was not suppressed by the same irradiation  procedure.  Over half 
of the chronic LCM carrier SWR/J mice treated with  cyclophosphamide for 
6 mo had total anti-LCM humoral immunosuppression, but showed no change 
in  the  level of virus carried.  The glomerulonephritis  which  occurs in chronic 
LCM carrier mice was prevented by cyclophosphamide treatment in 90%  of 
the mice. The humoral immune response which occurs in chronic LCM carrier 
mice appears to play no role in controlling the amount of virus carried by the 
mouse. Suppression of the LCM immune response by cyclophosphamide does 
prevent the development of glomerulonephritis in these mice. 
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